PT2568970T - Formulações farmacêuticas estáveis contendo um anti-histamínico - Google Patents
Formulações farmacêuticas estáveis contendo um anti-histamínicoInfo
- Publication number
- PT2568970T PT2568970T PT11723895T PT11723895T PT2568970T PT 2568970 T PT2568970 T PT 2568970T PT 11723895 T PT11723895 T PT 11723895T PT 11723895 T PT11723895 T PT 11723895T PT 2568970 T PT2568970 T PT 2568970T
- Authority
- PT
- Portugal
- Prior art keywords
- antihistaminic
- pharmaceutical formulations
- formulations containing
- stable pharmaceutical
- stable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10162403 | 2010-05-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2568970T true PT2568970T (pt) | 2019-02-11 |
Family
ID=42225047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT11723895T PT2568970T (pt) | 2010-05-10 | 2011-05-10 | Formulações farmacêuticas estáveis contendo um anti-histamínico |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP2568970B1 (pt) |
| ES (1) | ES2709487T3 (pt) |
| PT (1) | PT2568970T (pt) |
| WO (1) | WO2011141483A2 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109925289B (zh) * | 2019-04-11 | 2021-05-25 | 海南普利制药股份有限公司 | 地氯雷他定分散片 |
| BR112023000798A2 (pt) * | 2020-07-24 | 2023-02-07 | Genzyme Corp | Composições farmacêuticas compreendendo venglustat |
| CN114252540A (zh) * | 2022-01-08 | 2022-03-29 | 山东新华鲁抗医药有限公司 | 一种地氯雷他定含量测定方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE71699A1 (es) | 1997-02-07 | 1999-08-03 | Sepracor Inc | Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra |
| UA62976C2 (en) | 1997-07-02 | 2004-01-15 | Schering Corp | Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2-b]pyridine |
| US6506767B1 (en) | 1997-07-02 | 2003-01-14 | Schering Corporation | 8-chloro-6,11-dihydro-11-(4-piperidylidine)-5H-benzo[5,6]cyclohepta[1-2-b] pyridine |
| AU741201B2 (en) | 1998-07-10 | 2001-11-22 | Merck Sharp & Dohme Corp. | 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5H-benzo(5,6) cyclohepta (1,2-b)pyridine oral compositions |
| MX2007000632A (es) | 2004-07-16 | 2007-03-30 | Cipla Ltd | Composicion antihistaminica. |
| CA2547274A1 (en) | 2005-05-20 | 2006-11-20 | Dr. Reddy's Laboratories Limited | Stable desloratadine compositions |
| US20080118555A1 (en) * | 2005-10-20 | 2008-05-22 | Glenmark Pharmaceuticals Limited | Stable pharmaceutical composition containing desloratadine |
| CA2571933C (en) * | 2006-03-24 | 2015-05-05 | Pharmascience Inc. | A descarbonylethoxyloratadine containing pharmaceutical composition |
| WO2007140987A1 (en) | 2006-06-07 | 2007-12-13 | Sandoz Ag | Stable and bioavailable formulations and a novel form of desloratadine |
| CA2687019A1 (en) * | 2007-05-11 | 2008-11-20 | Ratiopharm Gmbh | Pharmaceutical composition comprising desloratadine |
| EP2269586B1 (en) * | 2009-07-01 | 2011-09-21 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Pharmaceutical composition comprising desloratadine |
-
2011
- 2011-05-10 WO PCT/EP2011/057560 patent/WO2011141483A2/en active Application Filing
- 2011-05-10 EP EP11723895.6A patent/EP2568970B1/en active Active
- 2011-05-10 PT PT11723895T patent/PT2568970T/pt unknown
- 2011-05-10 ES ES11723895T patent/ES2709487T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011141483A2 (en) | 2011-11-17 |
| ES2709487T3 (es) | 2019-04-16 |
| EP2568970B1 (en) | 2018-12-05 |
| EP2568970A2 (en) | 2013-03-20 |
| WO2011141483A3 (en) | 2012-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1259250A1 (zh) | 包含1-(β-D-吡喃葡萄糖基)-2-噻吩基-甲基苯衍生物的藥物製劑 | |
| EP2547333A4 (en) | STABLE BORTEZOMIB FORMULATIONS | |
| HRP20181896T1 (hr) | Farmaceutske formulacije | |
| EP2629786A4 (en) | COMPOSITIONS FOR THE ADMINISTRATION OF MEDICAMENTS | |
| EP2424509A4 (en) | MEDICINAL COMBINATION FORMULATIONS WITH DETERMINED DOSAGE | |
| GB2486567B (en) | Pharmaceutical formulation | |
| EP2496083A4 (en) | FORMULATION CONTAINING NICOTINE | |
| EP2582396A4 (en) | REMEDY FORMULATIONS WITH LONG-TERM EFFECT | |
| ZA201302012B (en) | Low dose pharmaceutical composition | |
| IL226554A (en) | Medicinal preparations containing alisporiovir | |
| AP2013006687A0 (en) | Formulations | |
| PT2568970T (pt) | Formulações farmacêuticas estáveis contendo um anti-histamínico | |
| IL221501A (en) | Medicinal product containing miramistine | |
| EP2473168A4 (en) | PHARMACEUTICAL FORMULATIONS FOR INDIBULIN | |
| AP2013006689A0 (en) | Formulations | |
| GB201012047D0 (en) | Pharmaceutical formulations | |
| GB201012046D0 (en) | Pharmaceutical formulations | |
| AP3434A (en) | Semisolid pharmaceutical formulations | |
| GB201113974D0 (en) | Stable vitamin c formulations | |
| GB201001335D0 (en) | Drug release formulations | |
| GB201005639D0 (en) | Drug delivery formulations | |
| GB201111577D0 (en) | Pharmaceutical formulations | |
| GB201010494D0 (en) | Formulations | |
| GB201008470D0 (en) | Formulations | |
| GB201008358D0 (en) | Formulations |